Nexus Pharmaceuticals

A US-based, family and minority-owned healthcare company specializing in innovative processes to make difficult-to-manufacture specialty and generic injectables

[Nexus Pharmaceuticals @NexusPharmaLLC]

We are thrilled to be exhibiting at the MSHP Fall Seminar tomorrow! Stop by booth #5 to connect with our team — let’s talk effective and innovative solutions to support your institution’s needs. See you there!
#MSHP2025

[Nexus Pharmaceuticals @NexusPharmaLLC]

Nexus is hitting the road this August!

Catch us at these upcoming trade shows:
- Hospital Pharmacy Buyer Conference | August 3–4 | Miami
- FSHP Annual Meeting | August 8–10 | Orlando
- HealthTrust University Conference | August 18–20 | San Antonio

#FSHP #HTU #HCPBuyers

[Nexus Pharmaceuticals @NexusPharmaLLC]

Dan Geffen and Drew Barbone will be representing Nexus Pharmaceuticals at the GSHP Summer Meeting this weekend in Amelia Island, Florida! Stop by our booth to learn more about how Nexus can support your organization. See you there!
#GSHP #NexusPharmaceuticals

[Nexus Pharmaceuticals @NexusPharmaLLC]

Heading to the TPA Summer Meeting this week? Stop by and say hello to David Farris from Nexus Pharmaceuticals! He’ll be on-site to chat with new and familiar faces about our mission and how our products are making an impact across the country.
#TPASummerMeeting

[Nexus Pharmaceuticals @NexusPharmaLLC]

Don't miss the chance to connect with Drew Barbone at ALSHP, June 22–24! Stop by Nexus' booth to discuss how we can help support your organization's needs. #NexusPharmaceuticals #ALSHP2025

[Nexus Pharmaceuticals @NexusPharmaLLC]

Nexus Pharmaceuticals is proud to share that on May 9, 2025, it won a patent litigation involving injectable cyclophosphamide.

Read the full press release here: https://t.co/fGp8dQWze2

#NexusPharmaceuticals #Generic #Cyclophosphamide

[Nexus Pharmaceuticals @NexusPharmaLLC]

We are pleased to announce that Nexus Pharmaceuticals' Methylene Blue Injection is now available!

For detailed information, please read the full press release: https://t.co/oLJfY7aHtm

#NexusPharmaceuticals #ProductLaunch #MethyleneBlue

[Nexus Pharmaceuticals @NexusPharmaLLC]

Say hello to ease and efficiency – our Baclofen Injection Convenience Kits are designed to streamline your treatment process, ensuring patients get the care they need, when they need it. Order through your Wholesaler today! 👨‍⚕️👩‍⚕️
#BaclofenKit #ConvenienceKit

[Nexus Pharmaceuticals @NexusPharmaLLC]

Introducing the Baclofen Injection Refill Kit – a convenience kit aimed at enhancing patient care and optimizing healthcare processes. Read the full press release here: https://t.co/osXWwf6m3v

[Nexus Pharmaceuticals @NexusPharmaLLC]

"Nexus Pharmaceuticals Nexus Pharmaceuticals, LLC is expanding their Fluorescein dosage options to include Fluorescein Injection, USP 25% in a 2 mL vial alongside Fluorescein Injection, USP 10% in a 5 mL vial." Read the full press release here: https://t.co/nDLMCiM3A2

[Nexus Pharmaceuticals @NexusPharmaLLC]

“We are very excited to be adding Tranexamic Acid to our product portfolio,” says Vince LoPiccolo, Vice President of Sales at Nexus. Read the full press release here: https://t.co/Pvly0gbbgb

#NexusPharmaceuticals #TranexamicAcid

[Nexus Pharmaceuticals @NexusPharmaLLC]

We are excited to announce that Nexus' Fluorescein Injection is now available through our new partner, Hilco Vision. We are grateful that this partnership will enable access of Fluorescein of a wider network of healthcare providers.
#Fluorescein #HilcoVision

[Nexus Pharmaceuticals @NexusPharmaLLC]

We are excited to announce the FDA approval of Nexus’ Tacrolimus Injection, the first and only available in a vial. Read the full press release here https://t.co/xkch8HfUyD
#FDAApproval #TacrolimusInjection

[Nexus Pharmaceuticals @NexusPharmaLLC]

Our team can't wait to see plenty of new and familiar faces next week in New Orleans. See you there? 🎉🎺
#NexusPharmaceuticals #ASHP24 #NewOrleans

[Nexus Pharmaceuticals @NexusPharmaLLC]

Become a part of the Nexus family! We're on the lookout for talented individuals to fill a variety of exciting roles. Learn more about these opportunities at https://t.co/LFf3ArZQAn.

#NexusPharmaceuticals #Hiring

[Nexus Pharmaceuticals @NexusPharmaLLC]

Nexus announces the FDA approval of Methylene Blue Injection, USP. "We are pleased to strengthen the supply of an AP-rated and TIAA compliant Methylene Blue Injection," says Sridhar Desikan, Chief Scientific Officer.

Read the full press release here: https://t.co/lJul9bO5x7

[Nexus Pharmaceuticals @NexusPharmaLLC]

We're excited to highlight Maurice Keys this month! As a dedicated member of our sales team, Maurice goes above and beyond to drive our success. Thank you, Maurice, for your hard work! 👏

Learn more about Maurice and his position at https://t.co/R4JRmjPCNF #Sales

[Nexus Pharmaceuticals @NexusPharmaLLC]

Visit https://t.co/vbgKMnvQ23 to learn more about our amazing marketing manager, Alicen Baran, who has been instrumental in driving our brand's growth and innovation. Thank you, Alicen, for all you do! 😁🤗
#NexusPharmaceuticals #EmployeeSpotlight #Marketing

[Nexus Pharmaceuticals @NexusPharmaLLC]

Say hello to stable drug supply. 👋
Order your supply of Fluorescein through your Wholesaler today.
#NexusPharmaceuticals #FluoresceinInjection

[Nexus Pharmaceuticals @NexusPharmaLLC]

A friendly reminder that Fluorescein, USP 10% is in stock at Nexus Pharmaceuticals! Order through your Wholesaler today to replenish your inventory and guarantee stable treatment for your patients. 💉#FluoresceinInjection #NexusPharmaceuticals